Incidental prostate cancer diagnosed following a transurethral resection of the prostate: A national database analysis in England

Abstract

Objectives:

The aim was to compare prostate cancer and all-cause mortality in patients diagnosed with prostate cancer following a transurethral resection of the prostate (TURP) (incidental prostate cancer, IPC), to men diagnosed with localised non-incidental prostate cancer (NIPC).

Patients and methods:

Men diagnosed with localised prostate cancer between 2000 and 2008 were identified from the English national cancer registry. Their records were linked to the Hospital Episode Statistics (HES) database of hospital admissions in England to identify men who had a TURP. Men were considered to have IPC if prostate cancer was diagnosed less than 60 days after TURP. Mortality rates were calculated using the Kaplan–Meier method. Mortality rate ratios (RR) comparing IPC and NIPC were calculated with multivariable Poisson regression adjusting for age group, co-morbidities, year of diagnosis and radical treatment.

Results:

A total of 192,960 men were included. Of these, 6666 (3.5%) had IPC and 186,294 (96.5%) NIPC. Median follow-up was 4.7 years (0.5–11.0). Ten-year prostate cancer mortality was 17.1% in IPC, 19.0% in NIPC. With adjustment, the prostate cancer-specific mortality in IPC was 30% lower than NIPC (RR 0.70, 95% CI 0.65–0.75, p<0.001), with no difference in all-cause mortality.

Conclusion:

Ten-year prostate cancer mortality in IPC was 17%. Men with IPC had lower prostate cancer-specific mortality than other prostate cancer patients.

Keywords

Incidental prostate cancer prostate cancer prostate cancer management transurethral prostatectomy

Get full access to this article

View all access options for this article.

References

Cantrell

DeKlerk

Eggleston

. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. J Urol 1981; 125: 516–520.

Humphrey

Vollmer

. The ratio of prostate chips with cancer: a new measure of tumor extent and its relationship to grade and prognosis. Human Pathol 1988; 19: 411–418.

Tombal

De Visccher

Cosyns

. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: A 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999; 84: 1015–1020.

Cheng

Bergstralh

Scherer

. Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer 1999; 85: 1300–1304.

Amakasu

Akimoto

Akakura

. Disease progression in stage A prostate cancer. Int J Urol 1995; 2: 39–43.

Brawn

Johnson

Speights

. Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH. Br J Cancer 1994; 69: 1098–1101.

Thompson

Zeidman

. Extended follow-up of stage A1 carcinoma of prostate. Urology 1989; 33: 455–458.

Blute

Zincke

Farrow

. Long-term followup of young patients with stage A adenocarcinoma of the prostate. J Urol 1986; 136: 840–843.

Epstein

Walsh

Brendler

. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). J Urol 1994; 152(Pt 2): 1721–1729.

10.

Roy

Horne

Raife

. Incidental carcinoma of prostate, Long-term follow-up. Urology 1990; 36: 210–213.

11.

Beynon

Busuttil

Newsam

. Incidental carcinoma of the prostate: selection for deferred treatment. Br J Urol 1983; 55: 733–736.

12.

Epstein

Paull

Eggleston

. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. J Urol 1986; 136: 837–839.

13.

Andrèn

Garmo

Mucci

. Incidence and mortality of incidental prostate cancer: a Swedish register-based study. Br J Cancer 2009; 100: 170–173.

14.

Capitanio

Briganti

Suardi

. When should we expect no residual tumor (pT0) once we submit incidental T1a-b prostate cancers to radical prostatectomy? Int J Urol 2011; 18: 148–153.

15.

Capitanio

Scattoni

Freschi

. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur Urol 2008; 54: 118–125.

16.

Heidenreich

Bastian

Bolla

EAU. Guidelines on Prostate Cancer, http://uroweb.org/wp-content/uploads/09_Prostate_Cancer_LR.pdf (2013, accessed 13 Aug 2013).

17.

National Cancer Intelligence Network (NCIN). Merged English Cancer Registry Data, http://www.ncin.org.uk/collecting_and_using_data/national_cancer_data_repository/cancer_registry (2010, accessed 3 Aug 2013)

18.

World Health Organization. ICD-10 Version: 2010, http://apps.who.int/classifications/icd10/browse/2010/en (2010, accessed 2 Sep 2013)

19.

NHS Connecting for Health. OPCS Classification of Interventions and Procedures Version 4.6 (April 2011) Volume 1 - Tabular List. London: The Stationery Office; 2011.

20.

Health and Social Care Information Centre. Data Linkage and Extract Service, http://www.hscic.gov.uk/dles (2013, accessed 12 Jan 2014)

21.

Nuttall

Van der Meulen

Emberton

. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 2006; 59: 265–273.

22.

Lu-Yao

Albertsen

Moore

. Outcomes of localized prostate cancer following conservative management. JAMA 2009; 302: 1202–1209.

23.

National Cancer Institue. Cancer of the Prostate - SEER Stat Fact Sheets, http://seer.cancer.gov/statfacts/html/prost.html (2010, accessed 28 Sep 2013)

24.

Office for National Statistics. Cancer incidence and mortality in the United Kingdom. Newport: 2013.

25.

Lee

Thiruneelakandasivam

Hong

. Are transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following transurethral resection of the prostate for benign disease? Urologia Internationalis. 2013; 91: 397–403.

26.

Sheu

Chiang

Wang

. Transurethral resection of the prostate-related changes in the prostate gland: correlation of MRI and histopathology. J Comput Assist Tomogr 2000; 24: 596–599.

27.

Barentsz

Richenberg

Clements

. ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746–757.